Bilimsel çalışmalar

Doç. Dr. Özlem Özkul

34 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. AGGF-1 Expression as a Predictive Biomarker for Anti-VEGF Therapy in Metastatic Colorectal Cancer

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.263054 Kaynak: OpenAlex

  2. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 atıf (Europe PMC) Kaynak: OpenAlex

  3. Assessment of Apparent Diffusion Coefficient Parameters and Coefficient of Variance in Discrimination of Receptor Status and Molecular Subtypes of Breast Cancer

    Current Medical Imaging, 2024

    DOI 10.2174/1573405620666230906092253 PMID 37691204 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  4. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

    Journal of Cancer Research and Clinical Oncology, 2023

    DOI 10.1007/s00432-023-04766-3 PMID 37067546 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  5. Evre 1-3 Kolon Kanserinde Radyolojik Tutulumun Lokalizasyonu ve Sağ Kalıma Etkisi

    Sakarya Medical Journal, 2023

    DOI 10.31832/smj.1210830 Açık erişimli tam metinKaynak: OpenAlex

  6. Protective Effects of Ibudilast Against Cisplatin-Induced Hepatotoxicity and Nephrotoxicity Mediated by Prostacyclin Enhancement

    International Journal of Pharmacology, 2023

    DOI 10.3923/ijp.2023.447.454 Kaynak: OpenAlex

  7. The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer

    Eurasian Journal of Medical Investigation, 2023

    DOI 10.14744/ejmi.2023.36214 Açık erişimli tam metinKaynak: OpenAlex

  8. Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

    Journal of Cancer Research and Clinical Oncology, 2022

    DOI 10.1007/s00432-022-04087-x PMID 35689097 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Gastrointestinal Sistem Tümörleri-1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1211 Açık erişimli tam metinKaynak: OpenAlex

  10. Impact of COVID-19 lockdown on mood status: A comparison of hemodialysis and oncology patients

    Therapeutic Apheresis and Dialysis, 2022

    DOI 10.1111/1744-9987.13767 PMID 34841690 4 atıf (Europe PMC) Kaynak: ORCID

  11. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT

    Current Medical Imaging, 2022

    DOI 10.2174/1573405618666220303105410 PMID 35240961 7 atıf (Europe PMC) Kaynak: ORCID

  12. The Value of18F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer,Lokal İleri Meme Kanserinde Neoadjuvan İnterim Kemoterapi Yanıtının Değerlendirilmesinde18F-FDG PET/BT Görüntülemenin Değeri

    Molecular Imaging and Radionuclide Therapy, 2022

    DOI 10.4274/mirt.galenos.2022.44154 PMID 35770978 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  13. Ameliorating Effect of Propofol on Cisplatin-Induced Liver and Kidney Damage in Rats

    International Journal of Pharmacology, 2022

    DOI 10.3923/ijp.2022.1623.1635 2 atıf (OpenAlex) Kaynak: OpenAlex

  14. The Investigation of Ameliorating Effect of Methylene Blue on Cisplatin-Induced Neurotoxicity in Female Rats

    Journal of Clinical and Experimental Investigations, 2022

    DOI 10.29333/jcei/11555 Açık erişimli tam metinKaynak: OpenAlex

  15. Protective effect of oxytocin through its anti-inflammatory and antioxidant role in a model of sepsis-induced acute lung injury: Demonstrated by CT and histological findings

    Experimental Lung Research, 2021

    DOI 10.1080/01902148.2021.1992808 PMID 34665057 13 atıf (Europe PMC) Kaynak: ORCID

  16. Comparative assessment of three different second-line regimens in chemotherapy resistant/refractory small-cell lung cancer

    Journal of B.U.ON., 2021

    PMID 33721436 1 atıf (OpenAlex) Kaynak: ORCID

  17. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

    PubMed, 2020

    PMID 33099930 5 atıf (Europe PMC) Kaynak: OpenAlex

  18. İnflamatuar Myofibroblastik Tümörler, Desmoid Tümörler, Dermatofibrosarkom Protuberans

    2020

    Kaynak: OpenAlex

  19. Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?

    European journal of rheumatology, 2019

    DOI 10.5152/eurjrheum.2019.19029 PMID 31657699 16 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  20. Correlations between estimating GFR methods and oncological outcomes during cancer chemotherapy

    Ortadoğu Tıp Dergisi, 2019

    DOI 10.21601/ortadogutipdergisi.499665 Açık erişimli tam metinKaynak: OpenAlex

  21. Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

    Cancer Chemotherapy and Pharmacology, 2018

    DOI 10.1007/s00280-018-3713-6 PMID 30374523 13 atıf (Europe PMC) Kaynak: OpenAlex

  22. A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; A hospital-based retrospective case series study

    Journal of B.U.ON., 2017

    PMID 29332358 21 atıf (OpenAlex) Kaynak: ORCID

  23. Paclitaxel-Carboplatin based therapy in elderly patients with Non-small Cell Lung Cancer

    Kocaeli Üniversitesi - AVESİS, 2017

    Kaynak: OpenAlex

  24. AB0724 The Frequency of The Metabolic Syndrome and Comparison of He Risk Factors for Cardiovascular Disease in Psoriasis, PSA and RA Groups

    Annals of the Rheumatic Diseases, 2016

    DOI 10.1136/annrheumdis-2016-eular.1891 Kaynak: OpenAlex

  25. THU0562 A Comparison Between Ankylosing Spondilitis Patients and Familial Mediterranean Fever with Ankylosing Spondilitis Patients

    Annals of the Rheumatic Diseases, 2015

    DOI 10.1136/annrheumdis-2015-eular.6315 3 atıf (OpenAlex) Kaynak: OpenAlex

  26. A case of spontaneous intracranial hypotension presenting as isolated permanent neck pain

    Clinical Neurology and Neurosurgery, 2013

    DOI 10.1016/j.clineuro.2013.07.046 PMID 24135447 Kaynak: ORCID

  27. Cerebral venous thrombosis,Thrombose veineuse cérébrale

    Revue du Praticien, 2013

    Kaynak: ORCID

  28. Intractable vomiting as first manifestation of neuromyelitis Optica,Vomissements récurrents inauguraux d'une neuromyélite optique de Devic

    Revue Neurologique, 2013

    DOI 10.1016/j.neurol.2012.04.003 PMID 22749336 1 atıf (Europe PMC) Kaynak: ORCID

  29. Post-operative edema surrounding the electrode: An unusual complication of deep brain stimulation.

    Brain Stimulation, 2013

    DOI 10.1016/j.brs.2012.05.012 PMID 22743074 28 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  30. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification

    Brain, 2013

    DOI 10.1093/brain/awt255 PMID 24065723 243 atıf (OpenAlex) Kaynak: OpenAlex

  31. [Cerebral venous thrombosis].

    PubMed, 2013

    PMID 24167897 1 atıf (OpenAlex) Kaynak: OpenAlex

  32. Efficacité des échanges plasmatiques chez 2 patientes NMO âgées

    Revue Neurologique, 2012

    DOI 10.1016/j.neurol.2012.01.101 Kaynak: OpenAlex

  33. Facteurs prédictifs de transformation hémorragique de l’infarctus cérébral par tomodensitométrie cérébrale multi-modalités

    Revue Neurologique, 2012

    DOI 10.1016/j.neurol.2012.01.243 Kaynak: OpenAlex

  34. Neuromyelitis optica with very late onset

    Journal of the American Geriatrics Society, 2011

    DOI 10.1111/j.1532-5415.2011.03435.x PMID 21668918 12 atıf (Europe PMC) Kaynak: ORCID